Skip to content

Electroencephalographic characteristics of transcutaneous auricular vagus nerve stimulation for the treatment of disorders of consciousness

Study on the brain effects and multimodal imaging mechanisms of transcutaneous auricular acupoint stimulation in patients with disorders of consciousness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000734
Enrollment
Unknown
Registered
2024-11-25
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

disorders of consciousness

Interventions

treatment group:taVNS treatment

Sponsors

Institute of Acupuncture and Moxibustion China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria for disorders of consciousness ; (2) Aged 18-70 years no gender restriction; (3) Disease duration of more than 1 month with failure of conventional awakening treatments; (4) Basic normal heart lung liver and kidney function; (5) Suitable for assessment (neuroimaging EEG various evoked potentials); (6) Presence of mismatch negativity (MMN) in EEG; (7) Expected survival time greater than 3 months; (8) Able to cooperate in monitoring adverse events and treatment efficacy; (9) The patient or their legal guardian signs a written informed consent form; (10) Female patients have a negative pregnancy test; (11) Normal coagulation function.

Exclusion criteria

Exclusion criteria: (1) Patients with comas due to neurodegenerative diseases intracranial infections or post-brain tumor surgery; (2) Patients whose consciousness has shown sustained improvement or deterioration within 1 month prior to enrollment; (3) Patients with severe complications; (4) Patients who have participated in other clinical trials within the past three months; (5) Patients with a history of severe allergies or allergic constitution; (6) Patients with other severe medical conditions or serious uncontrolled infections; (7) Patients with substance abuse drug addiction chronic alcoholism or HIV.

Design outcomes

Primary

MeasureTime frame
Coma Recovery Scale-Revised;

Secondary

MeasureTime frame
resting-state EEG;

Countries

China

Contacts

Public ContactJinling Zhang

Institute of Acupuncture and Moxibustion China Academy of Chinese Medical Sciences

jinlingzhang407@sina.com13511055995

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Sep 17, 2026